Sinofn Health
Sinofn Health
The global nutraceutical landscape is undergoing a paradigm shift. Consumers are moving away from traditional pill-form supplementation toward experiential, sensory-rich formats—primarily gummies. As a premier Private Label Gummies Manufacturer, SINOFN Health sits at the intersection of medical science and consumer preference.
Industry data indicates a compound annual growth rate (CAGR) for functional gummies exceeding 12% through 2030. This demand is driven by the "pill fatigue" phenomenon and the integration of health supplements into daily lifestyle habits rather than medicinal routines.
In the current global economic climate, supply chain reliability is non-negotiable. SINOFN leverages "China Factory 4.0" standards—characterized by IoT-driven manufacturing, full-stack transparency, and rapid iteration capabilities. Unlike traditional contract manufacturers, our production lines are built for agility, allowing global brands to pivot formulas in response to local market trends within weeks, not months.
With R&D centers backed by the Chinese Academy of Sciences, we ensure that every formulation meets the stringent standards of the FDA, EFSA, and TGA. Our commitment extends beyond simple manufacturing; we provide Information Gain to our partners by sharing stability data, bioavailability optimization, and shelf-life analysis that competitors often overlook.
Founded in 2012 by Mrs. GuoHong Liu, SINOFN Health Co., Ltd. represents the evolution of supplement contract manufacturing. Our journey began with a mission to solve accessibility issues for children with Phenylketonuria (PKU). This "Profit with Purpose" philosophy remains the bedrock of our corporate identity.
Today, as a dedicated OEM division, we provide end-to-end solutions for global supplement brands—from the initial formulation concept and pilot-scale prototyping at our Tianjin R&D center to full-scale GMP production in Shanghai.
Medical Innovation Director, PhD from Peking University. Expert in metabolic disorder formulations.
R&D Lead, CAS Postdoc. Specialist in advanced bioactive compound delivery systems.
Formulation Director, EU Regulatory Specialist. Leading our international industrialization strategies.
Collaborative R&D with top universities to ensure clinical efficacy in every gummy.
We combine deep medical research (R&D) with high-efficiency factory operations. Our ability to handle complex formulations—such as those with high nutrient density—sets us apart from standard mass-market gummy producers.
We utilize standardized, blockchain-tracked batch reporting to ensure 100% transparency. Our Shanghai trading hub is positioned for efficient global export, ensuring compliance with international logistics requirements.
Yes. Our pilot-scale prototyping capabilities allow us to support R&D and smaller initial production runs, helping emerging brands test market viability before full-scale commercialization.
